Venus Remedies Ltd.

NSE : VENUSREM

₹449.2

-9.25 (-2.02%) - 1 Jul 2025 03:59 PM

NSE : VENUSREM

About Company

Venus Remedies Limited is a research and innovation-driven Indian pharmaceutical company with a global footprint in many nations. The company has several manufacturing facilities, hundreds of market authorisations, many global patents and product basket. Its GLP-accredited Venus Medicine Research Centre (VMRC) is committed to offering the world novel breakthroughs catering to the critical care and super specialty segments. Its manufacturing facilities deliver world-class products accepted by regulators in advanced and developing pharmaceutical markets.

Market Cap. ₹ 613 Cr.

52 Week - High/Low ₹ 477/270

P/E Ratio 11.66

P/B Ratio 1.20

Enterprise Value ₹ 576 Cr.

ROE % 6.18

RSI Value 60.96

EMA 50 395.62

EMA 200 345.63

Market Cap. ₹ 613 Cr.

52 Week - High/Low ₹ 477/270

P/E Ratio 13.52